Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS vs BH.IMMUN&BIO - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KILITCH DRUGS BH.IMMUN&BIO KILITCH DRUGS/
BH.IMMUN&BIO
 
P/E (TTM) x 35.1 -5.8 - View Chart
P/BV x 2.8 1.1 249.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KILITCH DRUGS   BH.IMMUN&BIO
EQUITY SHARE DATA
    KILITCH DRUGS
Mar-24
BH.IMMUN&BIO
Mar-23
KILITCH DRUGS/
BH.IMMUN&BIO
5-Yr Chart
Click to enlarge
High Rs47052 907.0%   
Low Rs14121 687.8%   
Sales per share (Unadj.) Rs96.010.3 929.3%  
Earnings per share (Unadj.) Rs8.4-3.9 -219.1%  
Cash flow per share (Unadj.) Rs10.5-3.8 -276.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs109.420.4 535.6%  
Shares outstanding (eoy) m16.0843.18 37.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.23.5 90.9%   
Avg P/E ratio x36.2-9.4 -385.7%  
P/CF ratio (eoy) x29.0-9.5 -305.6%  
Price / Book Value ratio x2.81.8 157.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,9121,561 314.7%   
No. of employees `000NANA-   
Total wages/salary Rs m100151 66.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m1,544446 346.1%  
Other income Rs m4511 422.5%   
Total revenues Rs m1,589457 347.8%   
Gross profit Rs m243-161 -151.0%  
Depreciation Rs m342 1,675.0%   
Interest Rs m6071 85.5%   
Profit before tax Rs m194-223 -86.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m58-56 -102.7%   
Profit after tax Rs m136-166 -81.6%  
Gross profit margin %15.7-36.0 -43.6%  
Effective tax rate %29.925.3 118.1%   
Net profit margin %8.8-37.3 -23.6%  
BALANCE SHEET DATA
Current assets Rs m1,460358 407.8%   
Current liabilities Rs m642940 68.3%   
Net working cap to sales %53.0-130.6 -40.6%  
Current ratio x2.30.4 597.2%  
Inventory Days Days17385 202.0%  
Debtors Days Days1,4951,135 131.7%  
Net fixed assets Rs m9151,262 72.5%   
Share capital Rs m161432 37.2%   
"Free" reserves Rs m1,599450 355.0%   
Net worth Rs m1,759882 199.4%   
Long term debt Rs m00-   
Total assets Rs m2,3751,620 146.6%  
Interest coverage x4.2-2.2 -195.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.3 236.0%   
Return on assets %8.3-5.9 -139.6%  
Return on equity %7.7-18.9 -40.9%  
Return on capital %14.4-17.2 -83.7%  
Exports to sales %00-   
Imports to sales %014.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA65 0.0%   
Fx inflow Rs m7790-   
Fx outflow Rs m16665 257.6%   
Net fx Rs m613-65 -950.5%   
CASH FLOW
From Operations Rs m-1109 -1.3%  
From Investments Rs m-955 -2,066.0%  
From Financial Activity Rs m88-147 -59.9%  
Net Cashflow Rs m-9-34 26.3%  

Share Holding

Indian Promoters % 69.2 59.3 116.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 30.8 40.8 75.5%  
Shareholders   9,920 35,313 28.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KILITCH DRUGS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on KILITCH DRUGS vs BH.IMMUN&BIO

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

KILITCH DRUGS vs BH.IMMUN&BIO Share Price Performance

Period KILITCH DRUGS BH.IMMUN&BIO S&P BSE HEALTHCARE
1-Day -0.84% -3.03% 0.11%
1-Month -5.00% -11.61% -3.22%
1-Year -5.09% -9.00% 42.65%
3-Year CAGR 26.27% -22.03% 19.86%
5-Year CAGR 21.26% 23.61% 25.90%

* Compound Annual Growth Rate

Here are more details on the KILITCH DRUGS share price and the BH.IMMUN&BIO share price.

Moving on to shareholding structures...

The promoters of KILITCH DRUGS hold a 69.2% stake in the company. In case of BH.IMMUN&BIO the stake stands at 59.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of KILITCH DRUGS and the shareholding pattern of BH.IMMUN&BIO.

Finally, a word on dividends...

In the most recent financial year, KILITCH DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

BH.IMMUN&BIO paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of KILITCH DRUGS, and the dividend history of BH.IMMUN&BIO.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23% Sensex Today Falls 423 Points | Nifty Ends Near 23,350 | Adani Enterprises Cracks 23%(Closing)

On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.